×

CellRapeutics™ Leukopak from Fibromyalgia Donor (XS-0426-XU238)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This specialized Leukopak is collected from donors diagnosed with Fibromyalgia, providing access to the peripheral immune signatures of central sensitization syndromes. Research suggests altered cytokine profiles and small-fiber-related immune changes in these donors. This large-scale cellular collection allows for the high-depth analysis of "neuro-inflammation" markers and the study of the intersection between the immune system and chronic pain signaling pathways.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Fibromyalgia Donor
  • Cat. No.
  • XS-0426-XU238
  • Donor Age
  • Middle-Aged
  • Donor Health
  • Donors present with a central pain sensitization syndrome. The leukocyte profile exhibits subtle neuro-immune signaling alterations and markers of chronic physiological and oxidative stress.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Acid Citrate Dextrose, standard formulation focused on maintaining baseline metabolic states of peripheral mononuclear cells.
  • Additional Donor Information
  • Each lot features a Leukopak from donors meeting ACR criteria for fibromyalgia. Profiles include pain duration and comorbid symptom history, facilitating research into neuro-immune interactions and systemic cytokine profiles.
  • Clinical Profile
  • Duration of chronic widespread pain, presence of common comorbidities, and symptomatic treatment history.

Additional Information

  • Medication History
  • Available upon request. Includes history of gabapentinoids, SNRIs, tricyclic antidepressants, and various analgesic pharmacological interventions.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Fibromyalgia Donor, Leukopak, Fibromyalgia

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Fibromyalgia Donor (XS-0426-XU238). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.